Three members of the SIBLING family of integrin-binding phosphoglycoproteins (bone sialoprotein, BSP; osteopontin, OPN; and dentin matrix protein-1, DMP1) were recently shown to bind with high affinity (nM) and to activate 3 different matrix metalloproteinases (MMP-2, MMP-3, and MMP-9, respectively) in vitro. The current study was designed to document the possible biological relevance of the SIBLING-MMP activation pathway in vivo by showing that these 3 SIBLINGs and their known MMP partners are co-expressed in normal adult tissue. BSP, OPN, and DMP1 were invariably co-expressed with their partner MMPs in salivary glands of humans and mice. The 2 SIBLING proteins without known MMP partners, dentin sialophosphoprotein (DSPP) and matrix extracellular phosphoglycoprotein (MEPE), were also expressed in salivary glands. Expression of all SIBLINGs in this normal, non-mineralizing epithelial tissue suggests that they serve at least one function in vivo other than directly promoting matrix mineralization—a function we hypothesize involves local activation of MMPs.
Get full access to this article
View all access options for this article.
References
1.
Bellahcéne A, Menard S, Bufalino R, Moreau L, Castronovo V (1996). Expression of bone sialoprotein in primary human breast cancer is associated with poor survival. Int J Cancer69:350–353.
2.
Bianco P, Fisher LW, Young MF, Termine JD, Robey PG (1991). Expression of bone sialoprotein (BSP) in developing human tissues. Calcif Tissue Int49:421–426.
3.
Brown LF, Berse B, Van de Water L, Papadopoulos-Sergiou A, Perruzzi CA, Manseau EJ, et al. (1992). Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell3:1169–1180.
4.
Chaplet M, De Leval L, Waltregny D, Detry C, Fornaciari G, Bevilacqua G, et al. (2003). Dentin matrix protein 1 is expressed in human lung cancer. J Bone Miner Res18:1506–1512.
D’Souza RN, Cavender A, Sunavala G, Alvarez J, Ohshima T, Kulkarni AB, et al. (1997). Gene expression patterns of murine dentin matrix protein 1 (DMP1) and dentin sialophosphoprotein (DSPP) suggest distinct developmental functions in vivo. J Bone Miner Res12:2040–2049.
7.
Fedarko NS, Jain A, Karadag A, Fisher LW (2004). Three small integrin binding ligands N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. FASEB J18:734–736.
8.
Fisher LW, Whitson SW, Avioli LV, Termine JD (1983). Matrix sialoprotein of developing bone. J Biol Chem258:12723–12727.
9.
Fisher LW, McBride OW, Termine JD, Young MF (1990). Human bone sialoprotein. Deduced protein sequence and chromosomal localization. J Biol Chem265:2347–2351.
10.
Fisher LW, Stubbs JT 3rd, Young MF (1995). Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand266(Suppl):61–65.
11.
Fisher LW, Torchia DA, Fohr B, Young MF, Fedarko NS (2001). Flexible structure of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun280:460–465.
12.
George A, Silberstein R, Veis A (1995). In situ hybridization shows DMP1 (AG1) to be a developmentally regulated dentin-specific protein produced by mature odontoblasts. Connect Tissue Res33:67–72.
13.
Hirst KL, Ibaraki-O’Connor K, Young MF, Dixon MJ (1997). Cloning and expression analysis of the bovine dentin matrix acidic phosphoprotein gene. J Dent Res76:754–760.
14.
Jain A, Karadag A, Fohr B, Fisher LW, Fedarko NS (2002). Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H’s cofactor activity enabling MCP-like cellular evasion of complement-mediated attack. J Biol Chem277:13700–13708.
15.
Karadag A, Ogbureke KUE, Fedarko NS, Fisher LW (2004). Bone sialoprotein, matrix metalloproteinase 2, and αvβ3 integrin in osteotropic cancer cell invasion. J Natl Cancer Inst96:956–965.
16.
Kusafuka K, Yamaguchi A, Kayano T, Takemura T (1999). Expression of bone matrix proteins, osteonectin, and osteopontin, in salivary pleomorphic adenoma. Pathol Res Pract195:733–739.
17.
MacDougall M, Gu TT, Luan X, Simmons D, Chen J (1998). Identification of a novel isoform of mouse dentin matrix protein 1: spatial expression in mineralized tissues. J Bone Miner Res13:422–431.
18.
Mintz KP, Grzesik WJ, Midura RJ, Robey PG, Termine JD, Fisher LW (1993). Purification and fragmentation of nondenatured bone sialoprotein: evidence for a cryptic, RGD-resistant cell attachment domain. J Bone Miner Res8:985–995.
19.
Nagel H, Laskawi R, Wahlers A, Hemmerlein B (2004). Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland. Histopathology44:222–231.
20.
Patarca R, Wei FY, Singh P, Morasso MI, Cantor H (1990). Dysregulated expression of the T cell cytokine Eta-1 in CD4-8- lymphocytes during the development of murine autoimmune disease. J Exp Med172:1177–1183.
21.
Pinkstaff CA (1998). Salivary gland sexual dimorphism: a brief review. Eur J Morphol36(Suppl):31–34.
22.
Qin C, Brunn JC, Cadena E, Ridall A, Tsujigiwa H, Nagatsuka H, et al. (2002). The expression of dentin sialophosphoprotein gene in bone. J Dent Res81:392–394.
23.
Robey PG (2002). Bone proteoglycans and glycoproteins. In: Principles of bone biology. Bilezikian JP, Raisz LA, Rodan GA, editors. San Diego: Academic Press, pp. 225–238.
24.
Rowe PS, de Zoysa P, Dong R, Wang HR, White KE, Econs MJ, et al. (2000). MEPE, a new gene expressed in bone marrow and tumor causing osteomalacia. Genomics67:54–68.
25.
Senger DR, Perruzzi CA, Papadopoulos A, Tenen DG (1989). Purification of human milk protein similar to tumor-secreted phosphoproteins and osteopontin. Biochim Biophys Acta996:43–48.
26.
Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, Terrell CH, et al. (1992). Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA89:426–430.
27.
Waltregny D, Bellahcéne A, Van Riet I, Fisher LW, Young MF, Fernande P, et al. (1998). Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J Natl Cancer Inst90:1000–1008.
28.
Wu AJ, Lafrenie RM, Park C, Apinhasmit W, Chen ZJ, Birkedal-Hansen H, et al. (1997). Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-γ in a human salivary gland cell line. J Cell Physiol171:117–124.
29.
Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, et al. (1990). cDNA cloning, mRNA distribution and heterogeneity, chromosomal localization, and RFLP analysis of human osteopontin (OPN). Genomics7:491–502.
30.
Young MF, Ibaraki K, Kerr JM, Lyu MS, Kozak CA (1994). Murine bone sialoprotein (BSP): cDNA cloning, mRNA expression, and genetic mapping. Mamm Genome5:108–111.
